Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Benitec Biopharma Inc banner

Benitec Biopharma Inc
NASDAQ:BNTC

Watchlist Manager
Benitec Biopharma Inc Logo
Benitec Biopharma Inc
NASDAQ:BNTC
Watchlist
Price: 11.63 USD -4.04% Market Closed
Market Cap: $393.8m
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

Assets
+
3Y
+946%
5Y
-
10Y
-
Liabilities
+
3Y
+201%
5Y
-
10Y
-
Equity
+
3Y
+1 197%
5Y
-
10Y
-

Balance Sheet Decomposition
Benitec Biopharma Inc

Balance Sheet
Benitec Biopharma Inc

Rotate your device to view
Balance Sheet
Currency: USD
Jun-2001 Jun-2002 Jun-2003 Jun-2004 Jun-2005 Jun-2006 Jun-2007 Jun-2008 Jun-2009 Jun-2010 Jun-2011 Jun-2012 Jun-2013 Jun-2014 Jun-2015 Jun-2016 Jun-2017 Jun-2018 Jun-2019 Jun-2020 Jun-2021 Jun-2022 Jun-2023 Jun-2024
Assets
Cash & Cash Equivalents
0
1
0
3
5
1
4
0
0
0
0
1
1
0
1
14
13
12
16
10
20
4
2
0
Cash
0
1
0
3
5
1
4
0
0
0
0
1
1
0
1
0
0
0
0
5
20
0
0
0
Cash Equivalents
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14
13
12
16
5
0
4
2
0
Short-Term Investments
0
0
0
0
0
0
0
2
1
0
7
3
1
29
16
0
0
0
0
0
0
0
0
0
Total Receivables
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
1
3
3
3
0
0
0
0
0
Accounts Receivables
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
1
3
3
3
0
0
0
0
0
Other Receivables
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Inventory
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Current Assets
0
0
0
0
1
0
0
0
0
0
0
0
0
3
2
0
0
0
0
1
1
1
1
1
Total Current Assets
0
1
0
3
5
2
4
2
2
1
7
3
2
32
19
14
17
15
19
11
21
5
4
52
PP&E Net
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
0
PP&E Gross
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
0
Accumulated Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
0
Goodwill
0
8
9
15
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Long-Term Investments
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Long-Term Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
0
8
9
15
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Assets
1
N/A
10
+695%
10
-1%
19
+95%
6
-68%
2
-71%
4
+161%
2
-56%
2
-17%
1
-46%
7
+746%
3
-55%
2
-52%
33
+1 933%
20
-40%
15
-25%
17
+18%
16
-9%
19
+22%
12
-40%
21
+84%
6
-72%
4
-25%
52
+1 066%
Liabilities
Accounts Payable
0
0
0
1
1
1
1
0
0
1
1
0
0
1
1
1
1
2
1
0
0
0
1
1
Accrued Liabilities
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
2
3
3
Short-Term Debt
0
0
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Current Liabilities
1
0
1
1
2
1
0
0
0
0
1
0
1
0
1
0
0
0
1
0
0
0
0
0
Total Current Liabilities
1
1
5
2
3
2
1
1
0
1
1
1
1
1
1
1
1
2
3
1
1
3
4
5
Long-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Liabilities
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
Total Liabilities
1
N/A
1
+66%
5
+324%
2
-62%
3
+44%
2
-40%
1
-19%
1
-52%
1
+6%
1
+115%
2
+22%
1
-66%
1
+68%
1
-11%
1
+40%
1
-38%
1
+14%
2
+116%
3
+38%
1
-49%
1
+1%
3
+126%
4
+38%
5
+16%
Equity
Common Stock
4
13
15
33
48
49
62
70
60
65
93
89
82
122
100
110
120
121
115
0
0
0
0
0
Retained Earnings
3
4
11
17
45
49
58
68
59
66
87
87
80
89
80
96
103
108
98
117
130
148
168
190
Additional Paid In Capital
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
129
152
152
169
238
Other Equity
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
0
0
0
1
2
1
1
1
1
Total Equity
1
N/A
9
+1 571%
5
-45%
17
+264%
3
-81%
0
-98%
3
+6 080%
1
-58%
1
-28%
1
N/A
6
N/A
3
-51%
1
-78%
32
+5 261%
18
-42%
14
-24%
17
+18%
14
-16%
17
+20%
10
-38%
20
+95%
3
-86%
0
-93%
47
+23 400%
Total Liabilities & Equity
1
N/A
10
+695%
10
-1%
19
+95%
6
-68%
2
-71%
4
+161%
2
-56%
2
-17%
1
-46%
7
+746%
3
-55%
2
-52%
33
+1 933%
20
-40%
15
-25%
17
+18%
16
-9%
19
+22%
12
-40%
21
+84%
6
-72%
4
-25%
52
+1 066%
Shares Outstanding
Common Shares Outstanding
0
0
0
0
1
1
1
1
1
1
2
2
3
7
7
9
8
15
15
0
0
0
2
10

See Also

Summary
BNTC intrinsic value, competitors valuation, and company profile.
DCF Valuation
BNTC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BNTC stock valuation using valuation multiples.
Wall Street Estimates
BNTC price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BNTC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 316,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.